首页> 外文期刊>Antiviral Research >PA subunit of RNA polymerase as a promising target for anti-influenza virus agents.
【24h】

PA subunit of RNA polymerase as a promising target for anti-influenza virus agents.

机译:RNA聚合酶的PA亚基是抗流感病毒制剂的有希望的靶标。

获取原文
获取原文并翻译 | 示例
           

摘要

RNA polymerase of influenza virus is a specific enzyme necessary for the viral replication. A siRNA against the RNA polymerase and the RNA polymerase inhibitor L-742,001 reduced accumulation of viral RNAs in the infected cells. L-742,001 strongly inhibited virus re-growth after removal of the agent from the culture, whereas the neuraminidase inhibitor zanamivir did not. L-742,001-resistant mutants showed a Thr-20 to Ala substitution in the PA subunit of RNA polymerase. The drug-resistant virus showed a slight reduction in the susceptibility to L-742,001 in both the plaque assay (threefold reduction) and enzyme assay (two- to three-fold reduction). The resistance levels were lower than those of zanamivir-resistant mutants in the plaque assay. Against zanamivir-resistant mutants, L-742,001 retained the same antiviral activity as against the wild-type strain. These results indicate that L-742,001 is most likely to act at the PA subunit, and possesses a unique profile. It is suggested that PA subunit of RNA polymerase is a promising target for anti-influenza virus agents.
机译:流感病毒的RNA聚合酶是病毒复制所必需的特定酶。针对RNA聚合酶和RNA聚合酶抑制剂L-742,001的siRNA减少了病毒RNA在感染细胞中的积累。 L-742,001在从培养液中去除药剂后强烈抑制了病毒的重新生长,而神经氨酸酶抑制剂扎那米韦则没有。耐L-742,001的突变体在RNA聚合酶的PA亚基中显示出Thr-20取代Ala。耐药病毒在噬菌斑测定(减少三倍)和酶测定(减少两到三倍)中均显示出对L-742,001的敏感性略有降低。在噬斑测定中,抗药性水平低于对扎那米韦抗药的突变体。对于耐扎那米韦的突变体,L-742,001保留了与野生型菌株相同的抗病毒活性。这些结果表明,L-742,001最有可能作用于PA亚基,并具有独特的特征。提示RNA聚合酶的PA亚基是抗流感病毒试剂的有希望的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号